Year Established :
2009
Total Assets(USD) :
More than 99,999,999
Total Number of Staff :
100-500
Main Competitive Advantages :
International Approvals/Standards,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Other Competitive Advantages :
ISO Certificates.
Business Type :
Trading Company,Manufacturer
R&D Capacity :
Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
North America,Western Europe,Asia
Product Range :
Chloroalkanes: 1-Chloropropane, 2-Chloropropane, 1,3-Dichloropropane, 3-Chloro-1-propanol 1-Chlorobutane, 2-Chlorobutane, Ter-Butyl Chloride, 1,4-Dichlorobuatane, 1-Chloropentane, 1-Chlorohexane, 1-Chlorooctane, 1,6-Dichlorohexane,
Bromoalkanes: Bromoethane,1-Bromopropane, 2-Bromopropane, 1-Bromobutane, 1-Bromooctane, 1-Bromohexance, 1,4-Dibromobutane, 1,6-Dibromohexane, (2-Bromoethyl)benzene，
Pharse Transfer Catalyst: Tetrabutylammonium Bromide(TBAB); Tetrapropylammonium Bromide(TPAB); Benzyltriethylammonium Chloride(TEBA)
New Products: 4-Chlorotoluene, 4-Chlorobenzaldehyde,4-Chlorobenzoic Acid,4-Chlorobenzyl Chloride, 2-Chlorotoluene, 2-Chlorobenzaldehyde,2-Chlorobenzoic Acid , 2-Chlorobenzyl Chloride, 2,4-Dichlorotoluene, 2,4-Dichlorobenzaldehyde, 2,4-Dichlorobenzyl Chloride, 2,6-Dichlorotoluene, 2,6-Dichlorobenzaldehyde, 3,4-Dichlorobenzonitrile
Four years of qualification
Audited Supplier
Pharma Sources Insight January 2025
